Goldman Sachs maintains a Buy rating on Biren (6082.HK), citing China AI demand, product upgrades, and capacity assurance as growth drivers
AI summary card
Goldman Sachs maintains a Buy rating on Biren (6082.HK), citing China AI demand, product upgrades, and capacity assurance as growth drivers
The report believes Biren is shifting from older products such as BR106 and BR110 to the BR166, BR20X, BR30X, and BR31X series, and that higher computing power and ASPs should support improvements in revenue, profitability, and cash flow.
- Management remains optimistic about China AI demand, supported by growth in foundation models, AI agents, and applications, as well as local customers' need to diversify suppliers amid geopolitical conditions.
- The product mix is upgrading toward higher-power AI chips: the BR166 series has a maximum TDP of 600W, above the BR106 series' maximum of 400W; BR20X will support broader data formats such as FP8 and FP4, and will improve memory, interconnect bandwidth, and per-card compute power.
- The company has Rmb1.2bn of orders in hand, significantly above 1H25 revenue of Rmb59m; management emphasized cooperation with leading local foundries to secure delivery.
- Goldman Sachs expects Biren's 2025-2028E revenue CAGR to be +139%, reaching Rmb13bn in revenue by 2028E.
- The 12-month target price is HK$54.00, based on 46.6x 2030E EV/EBITDA and discounted back to 2027E at a 12.7% cost of equity.
Report interpretation
Overview
This is a Goldman Sachs company research report on Biren (6082.HK). Based on feedback from a recent visit with Biren's founder and management, the report highlights strong China AI demand, rising demand from local customers to diversify supply chains, a product mix shift toward higher-compute and higher-ASP chips, and the importance of capacity assurance for future revenue growth.
Core views
The core view is that Biren's growth will be driven by three main forces. First, China AI demand is being lifted by the expansion of foundation models, AI agents, and applications. Second, the company is gradually shifting from products launched in 2023-2024 to higher-spec products such as BR166 and BR20X/BR30X, which should bring higher dollar content and stronger compute performance. Third, close cooperation with leading local foundries should help improve delivery capability and capture strong local demand. Goldman Sachs therefore maintains its Buy rating.
Analysis framework
The report uses company diligence, management interviews, product roadmap analysis, order and revenue comparisons, earnings forecasts, and a relative valuation framework. On valuation, Goldman Sachs uses 46.6x 2030E EV/EBITDA as the target multiple and discounts it back to 2027E using a 12.7% cost of equity to derive a 12-month target price of HK$54.
Methodology notes
Estimate enterprise value using a forward EV/EBITDA multiple, then discount it to the target year using the cost of equity.
The report's 12-month target price of HK$54 is based on 46.6x 2030E EV/EBITDA and discounted back to 2027E at a 12.7% cost of equity.
Goldman Sachs compares stocks with the market and peers using growth, financial return, valuation multiples, and composite factors.
The growth factor uses forward sales, EBITDA, and EPS growth; the financial return factor uses ROE, ROCE, and CROCI; and the multiple factor uses metrics such as P/E, P/B, EV/EBITDA, and EV/FCF.
Goldman Sachs uses an M&A rank from 1 to 3 to assess a company's likelihood of becoming an acquisition target.
This report shows Biren's M&A Rank as 3, indicating a low probability of M&A and typically not included in the target price.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Biren (6082.HK)Covered company and recommended name in the report
- Strengths
- Benefiting from China AI demand expansion, customer demand for supplier diversification, product spec upgrades, a relatively high order backlog, and cooperation with local foundries.
- Weaknesses
- Current financial forecasts still show EBITDA, EPS, and free cash flow indicators under pressure in the near term, and the valuation relies partly on future revenue and earnings delivery.
- Comparison
- The report positions the company in the context of China AI chips and Greater China Technology, and derives the target valuation multiple using peers' forward EV/EBITDA and EBITDA growth relationships.
- Risks
- China AI chip demand may be weaker than expected, competition may be stronger than expected, and wafer supply constraints could affect GPU board shipments.
Key data
- RatingBuyGoldman Sachs maintains a Buy rating.
- 12-month target priceHK$54.00Based on 46.6x 2030E EV/EBITDA and discounted back to 2027E.
- Current priceHK$28.36The chart shows the price as of the close on 2026-03-30.
- Implied upside90.4%Derived from the comparison between the target price and the current price.
- Orders in handRmb1.2bnManagement disclosed that orders in hand are relatively high versus 1H25 revenue of Rmb59m.
- 2025-2028E revenue CAGR+139%Goldman Sachs expects revenue to reach Rmb13bn by 2028E.
- 2028E revenueRmb13bnGoldman Sachs forecast.
- 2024A revenueRmb336.8mnGS Forecast table data.
- 2025E revenueRmb945.4mnGS Forecast table data.
- 2026E revenueRmb1,919.0mnGS Forecast table data.
- 2027E revenueRmb5,588.8mnGS Forecast table data.
- Market capHK$69.2bn / US$8.8bnDisclosed in chart.
- Enterprise valueHK$60.6bn / US$7.7bnDisclosed in chart.
Impact & implications
If China AI demand continues to grow and the company completes product iterations such as BR166, BR20X, and BR30X as planned, Biren may improve ASP and revenue scale through higher-compute products, while also enhancing profitability and free cash flow. Capacity assurance and cooperation with local supply chains are critical to converting orders and revenue growth into reality.
Risks
- China AI chip demand may be weaker than expected.
- Competition may be stronger than expected.
- Wafer supply may be constrained, affecting GPU board shipments.
- Delays in the product roadmap or capacity delivery could affect the pace of revenue, earnings, and cash flow improvement.
- Goldman Sachs disclosed that it may have business relationships with the covered company, and investors should treat this report as only one factor in investment decisions.
What to watch
- Shipment pace after BR166 L/M mass production in August 2025.
- Customer adoption after BR166 C mass production in December 2025.
- Launch and performance delivery of the BR20X series in 2H26.
- Progress in product iterations of the BR30X and BR31X series through 2028.
- The speed at which the Rmb1.2bn order backlog converts into revenue.
- Local foundry capacity support and wafer supply stability.
- Changes in demand for foundation models, AI agents, and multimodal generative AI in China.